Page 1 of Clinical Trials for Drug Rasburicase SR29142, 23 Total Matches
- 1CompletedLast Updated: March 17, 2012Condition(s): Drug/Agent Toxicity by Tissue/Organ; Leukemia; Lymphoma
- 2CompletedLast Updated: January 8, 2010Condition(s): Tumor Lysis Syndrome; Cancer; Hyperuricemia
- 3CompletedLast Updated: March 27, 2009Condition(s): Tumors; Hyperuricemia; Tumor Lysis Syndrome
- 4RecruitingLast Updated: October 23, 2008Condition(s): Hyperuricemia
- 5CompletedLast Updated: March 27, 2009Condition(s): Nutritional and Metabolic Diseases
- 6CompletedLast Updated: October 5, 2011Condition(s): Leukemia; Lymphoma; Tumor Lysis Syndrome; Hyperuricemia
- 7RecruitingLast Updated: May 9, 2012Condition(s): Healthy Volunteers
- 8RecruitingLast Updated: March 23, 2012Condition(s): Adult Acute Myeloid Leukemia With 11q23 (MLL) Abnormalities; Adult Acute Myeloid Leukemia With Del(5q); Adult Acute Myeloid Leukemia With Inv(16)(p13;q22); Adult Acute Myeloid Leukemia With t(15;17)(q22;q12); Adult Acute Myeloid Leukemia With t(16;16)(p13;q22); Adult Acute Myeloid Leukemia With t(8;21)(q22;q22); Blastic Phase Chronic Myelogenous Leukemia; Contiguous Stage II Adult Burkitt Lymphoma; de Novo Myelodysplastic Syndromes; Noncontiguous Stage II Adult Burkitt Lymphoma; Previously Treated Myelodysplastic Syndromes; Recurrent Adult Acute Lymphoblastic Leukemia; Recurrent Adult Acute Myeloid Leukemia; Recurrent Adult Burkitt Lymphoma; Stage I Adult Burkitt Lymphoma; Stage III Adult Burkitt Lymphoma; Stage IV Adult Burkitt Lymphoma; Untreated Adult Acute Lymphoblastic Leukemia; Untreated Adult Acute Myeloid Leukemia
- 9RecruitingLast Updated: February 11, 2010Condition(s): Hyperuricemia
- 10RecruitingLast Updated: April 23, 2012Condition(s): Leukemia; Lymphoma
- 11TerminatedLast Updated: January 24, 2012Condition(s): Hyperuricemia
- 12RecruitingLast Updated: February 16, 2012Condition(s): Chronic Myeloproliferative Disorders; Graft Versus Host Disease; Leukemia; Lymphoma; Multiple Myeloma and Plasma Cell Neoplasm; Myelodysplastic Syndromes; Myelodysplastic/Myeloproliferative Neoplasms
- 13CompletedLast Updated: August 20, 2010Condition(s): Adult Acute Lymphocytic Leukemia; High-Grade Lymphoma
- 14CompletedLast Updated: May 24, 2012Condition(s): Tumor Lysis Syndrome
- 15CompletedLast Updated: August 4, 2009Condition(s): Leukemia; Lymphoma; Tumor Lysis Syndrome
- 16CompletedLast Updated: October 1, 2009Condition(s): Hyperuricemia; Leukemia; Lymphoma
- 17CompletedLast Updated: March 31, 2008Condition(s): Tumor Lysis Syndrome
- 18TerminatedLast Updated: March 6, 2012Condition(s): Hyperuricemia
- 19Completed
- 20CompletedLast Updated: January 24, 2008Condition(s): Hyperuricemia
Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.
The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Drug+Rasburicase+SR29142
